Analysis of One Patient with Infection by Carbapenem-resistant Escherichia Coli
- VernacularTitle:1例耐碳青霉烯大肠埃希菌感染患者治疗分析
- Author:
Kezhen FENG
1
,
2
;
Sasa HU
Author Information
1. 西安交通大学第一附属医院药学部 西安710061
2. 西安高新医院药剂科
- Keywords:
Carbapenem-resistant escherichia coli;
Infection;
Drug treatment;
Clinical pharmacists
- From:
China Pharmacist
2018;21(5):889-892
- CountryChina
- Language:Chinese
-
Abstract:
To evaluate the medication for one patient with the infection by carbapenem-resistant escherichia coli (CRE) to provide reference for the treatment of drug-resistance bacteria in clinical practice. During the development of anti-infective treatment regimen, clinical pharmacists analyzed and evaluated the situation, and provided suggestions for the medication:amikacin combined with fosfomycin and tigecycline. Physician adopted the recommendations,and the infective symptoms obtained a better control. The participation of clinical pharmacists in the treatment of intractable infection practice can provide reasonable and effective medication recommendations for clinics to improve anti-infective effectiveness in clinics.
